Traipsing Through Muddy Waters: A Critical Review of the Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) Overlap Syndromes |
Apr 2021 |
Hematology/oncology clinics of North America |
Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN) |
Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes |
Dec 2020 |
Hematology/oncology and stem cell therapy |
Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) |
Future directions in myelodysplastic syndromes/neoplasms and acute myeloid leukaemia classification: from blast counts to biology |
Oct 2024 |
Histopathology |
Myelodysplastic Syndromes (MDS) |
Plain language summary of RACE study results: addition of eltrombopag to standard treatment of severe aplastic anemia |
Dec 2023 |
Immunotherapy |
Aplastic Anemia |
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases |
Apr 2023 |
Internal and Emergency Medicine |
Myelodysplastic Syndromes (MDS) |
Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia |
Oct 2023 |
International Journal of Hematology |
Aplastic Anemia |
Allogeneic bone marrow transplantation for aplastic anemia |
Dec 2022 |
International Journal of Hematology |
Aplastic Anemia |
Aplastic anemia: history and recent developments in diagnosis and treatment |
Feb 2024 |
International Journal of Hematology |
Aplastic Anemia |
Recent advances in the diagnosis and treatment of pediatric acquired aplastic anemia |
Mar 2023 |
International Journal of Hematology |
Aplastic Anemia |
High Serum Ferritin Levels in Newly Diagnosed Patients With Myelodysplastic Syndromes Are Associated With Greater Symptom Severity |
Jun 2020 |
International Journal of Hematology |
Myelodysplastic Syndromes (MDS) |